Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients’ lives, while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular disease and other specialty areas. Aralez’s Global Headquarters is in Ontario, Canada and the Ireland Headquarters is in Dublin, Ireland.